Tevogen grants CEO Ryan Saadi 50 million restricted shares
น้อยกว่า 1 นาทีในการอ่าน
Tevogen granted CEO and Board Chair Ryan Saadi a 50 million-share restricted stock award tied to a revenue target.
| Individual | Ryan Saadi |
| Role | Chief Executive Officer and Chairperson of the Board |
| Type of Change | Restricted stock award |
| Effective Date | November 2, 2026 |
| Reason | Retention and incentive alignment with the Company’s long-term growth strategy |
| Compensation/Agreement Terms | Award covers 50 million shares; vesting requires Board certification of $1 billion in aggregate revenue by December 31, 2031, plus other conditions. Unvested shares are subject to forfeiture, including upon termination of service. |
Original SEC Filing: Tevogen Inc. [ TVGN ] - 8-K - Nov. 02, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.